Ehab Zekri
Family · Milford, MANPI 1295306280
Payments from drug & device makers
Across 152 payments — averaging $28.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$646
- Novo Nordisk$544
- Lilly USA, LLC$450
- Bayer$369
- Corcept Therapeutics$301
- Sanofi-aventis U.S. LLC$295
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 21 | $646 |
| Novo Nordisk | 20 | $544 |
| Lilly USA, LLC | 19 | $450 |
| Bayer | 15 | $369 |
| Corcept Therapeutics | 8 | $301 |
| Sanofi-aventis U.S. LLC | 3 | $295 |
| Kyowa Kirin, Inc. | 5 | $229 |
| Xeris Pharmaceuticals, Inc. | 7 | $151 |
| AstraZeneca(2 entities) | 6 | $136 |
| Mannkind Corporation | 5 | $129 |
| Idorsia Pharmaceuticals US Inc | 2 | $125 |
| Abbott | 1 | $115 |
| Boehringer Ingelheim | 5 | $113 |
| Tandem Diabetes Care, Inc. | 4 | $103 |
| Esperion Therapeutics, Inc. | 5 | $82 |
| Medtronic | 4 | $80 |
| Madrigal Pharmaceuticals | 3 | $73 |
| Antares Pharma, Inc. | 2 | $66 |
| Novartis | 4 | $63 |
| Dexcom, Inc. | 3 | $57 |
| Amneal Pharmaceuticals LLC | 2 | $45 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| GSK | 1 | $26 |
| Amryt Pharma Holdings Ltd | 1 | $25 |
| RGH Enterprises LLC | 1 | $25 |
| Tolmar, Inc. | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $20 |
| AbbVie | 1 | $19 |
| Cequr Corporation | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,348 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 331 | $431,990 |
| JardianceEmpagliflozin | 388 | $394,033 |
| MounjaroTirzepatide | 193 | $271,195 |
| FarxigaDapagliflozin Propanediol | 163 | $151,994 |
| TrulicityDulaglutide | 54 | $92,285 |
| RybelsusSemaglutide | 39 | $70,368 |
| Tresiba Flextouch U-200Insulin Degludec | 54 | $65,431 |
| Tresiba Flextouch U-100Insulin Degludec | 73 | $51,951 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 38 | $33,885 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 20 | $26,259 |
| KerendiaFinerenone | 21 | $25,337 |
| Humalog Kwikpen U-100Insulin Lispro | 76 | $24,155 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 167 | $23,991 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 44 | $20,925 |
| Novolog FlexpenInsulin Aspart | 50 | $19,045 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $544 | $502,358370 claims |
| Boehringer IngelheimJardiance | $113 | $394,033388 claims |
| Lilly USA, LLCMounjaro, Trulicity | $450 | $363,479247 claims |
| AstraZenecaFarxiga | $136 | $151,994163 claims |
| BayerKerendia | $369 | $25,33721 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $45 | $2,312194 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,320 family providers in Massachusetts.
Other family in Milford
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.